Diego Lucero

673 total citations
27 papers, 511 citations indexed

About

Diego Lucero is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Diego Lucero has authored 27 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Epidemiology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Diego Lucero's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Lipid metabolism and disorders (6 papers). Diego Lucero is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Lipid metabolism and disorders (6 papers). Diego Lucero collaborates with scholars based in Argentina, United States and Japan. Diego Lucero's co-authors include Laura Schreier, Valeria Zago, Gabriela Berg, Verónica Miksztowicz, Alan T. Remaley, Graciela López, E Fassio, Anna Wolska, Maureen Sampson and Russell Warnick and has published in prestigious journals such as Circulation, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Diego Lucero

26 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Lucero Argentina 15 259 221 150 116 86 27 511
Bruno Vergès France 9 261 1.0× 209 0.9× 174 1.2× 62 0.5× 58 0.7× 14 466
Tadeja Pintar Slovenia 7 202 0.8× 415 1.9× 109 0.7× 51 0.4× 114 1.3× 23 642
Sanja Sädevirta Finland 9 278 1.1× 389 1.8× 86 0.6× 107 0.9× 136 1.6× 12 653
Sanja Stojsavljević Croatia 9 127 0.5× 357 1.6× 66 0.4× 65 0.6× 68 0.8× 16 477
Tommy Pacana United States 9 235 0.9× 577 2.6× 162 1.1× 66 0.6× 127 1.5× 20 848
Vicência Mara Rodrigues de Lima Brazil 13 224 0.9× 400 1.8× 185 1.2× 44 0.4× 162 1.9× 15 679
Pedro Fernández-Gil Spain 5 265 1.0× 552 2.5× 118 0.8× 89 0.8× 97 1.1× 6 671
Qian Zhuang China 13 84 0.3× 119 0.5× 97 0.6× 56 0.5× 59 0.7× 26 490
Camilla Skoglund-Andersson Sweden 7 174 0.7× 62 0.3× 127 0.8× 89 0.8× 60 0.7× 8 367
Han De-wu China 10 114 0.4× 171 0.8× 90 0.6× 30 0.3× 111 1.3× 28 493

Countries citing papers authored by Diego Lucero

Since Specialization
Citations

This map shows the geographic impact of Diego Lucero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Lucero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Lucero more than expected).

Fields of papers citing papers by Diego Lucero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Lucero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Lucero. The network helps show where Diego Lucero may publish in the future.

Co-authorship network of co-authors of Diego Lucero

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Lucero. A scholar is included among the top collaborators of Diego Lucero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Lucero. Diego Lucero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucero, Diego, et al.. (2025). Molecular Mechanisms and Emerging Precision Therapeutics in the Gut Microbiota-Cardiovascular Axis. Cureus. 17(4). e83022–e83022. 2 indexed citations
2.
Tang, Jingrong, Diego Lucero, Wenling Li, et al.. (2024). Abstract 4147066: Octacosanol Reduces Lipopolysaccharide Induced Loss of Cellular Integrity of Primary Human Aorta Endothelial Cells. Circulation. 150(Suppl_1). 1 indexed citations
3.
Gordon, Scott M., Denis Sviridov, Angel Aponte, et al.. (2022). A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross Linking. International Journal of Molecular Sciences. 23(19). 11480–11480. 14 indexed citations
4.
Lucero, Diego, et al.. (2022). Lipoprotein Assessment in the twenty-first Century. Endocrinology and Metabolism Clinics of North America. 51(3). 459–481. 5 indexed citations
5.
Lucero, Diego, Ozan Dikilitas, Michael Mendelson, et al.. (2021). Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen. Journal of Lipid Research. 63(1). 100160–100160. 14 indexed citations
6.
Lucero, Diego, Lita A. Freeman, Xueting Jin, et al.. (2019). Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(2). 158537–158537. 21 indexed citations
7.
Lucero, Diego, et al.. (2019). Fetal and postnatal zinc restriction: Sex differences in metabolic alterations in adult rats. Nutrition. 65. 18–26. 12 indexed citations
8.
Inzaugarat, María Eugenia, Elena De Matteo, Plácida Baz, et al.. (2017). New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans. PLoS ONE. 12(3). e0172900–e0172900. 55 indexed citations
9.
Lucero, Diego, Verónica Miksztowicz, Cristina Longo, et al.. (2017). Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins. Clinica Chimica Acta. 473. 1–8. 27 indexed citations
10.
Lucero, Diego, Graciela López, Susana Gorzalczany, et al.. (2016). Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndrome. Clinical Biochemistry. 49(12). 932–935. 17 indexed citations
11.
Lucero, Diego, Denis Sviridov, Lita A. Freeman, et al.. (2015). Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT. Atherosclerosis. 242(1). 236–242. 31 indexed citations
12.
Lucero, Diego, Verónica Miksztowicz, Sílvia Friedman, et al.. (2015). Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α. Clínica e Investigación en Arteriosclerosis. 27(4). 167–174. 18 indexed citations
13.
Wikinski, Regina, et al.. (2013). Epidemiología Inversa: baja concentración de LDL modificadas y morbimortalidad cardiovascular en pacientes en hemodiálisis. Acta bioquímica clínica latinoamericana. 47(1). 95–100.
14.
Zago, Valeria, Susana Gorzalczany, Diego Lucero, Carlos A. Taira, & Laura Schreier. (2013). Role of HDL in neutralizing the VLDL effect on endothelial dysfunction. Microvascular Research. 89. 153–158. 10 indexed citations
15.
Bryk, Gabriel, et al.. (2012). Effect of dietary calcium (Ca) on body composition and Ca metabolism during growth in genetically obese (β) male rats. European Journal of Nutrition. 52(1). 297–305. 6 indexed citations
16.
Lucero, Diego, Valeria Zago, Graciela López, et al.. (2012). Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography. Clinical Biochemistry. 45(4-5). 293–297. 24 indexed citations
17.
Zago, Valeria, Diego Lucero, Verónica Miksztowicz, et al.. (2010). Circulating Very-Low-Density Lipoprotein Characteristics Resulting from Fatty Liver in an Insulin Resistance Rat Model. Annals of Nutrition and Metabolism. 56(3). 198–206. 19 indexed citations
18.
Lucero, Diego, Valeria Zago, Graciela López, et al.. (2010). Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?. Clinica Chimica Acta. 412(7-8). 587–592. 25 indexed citations
19.
Lucero, Diego, Valeria Zago, Graciela López, et al.. (2010). Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome. Clinica Chimica Acta. 412(1-2). 143–147. 30 indexed citations
20.
Borges, Jorge Luís, et al.. (1997). Cuentos de fútbol argentino. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Vergès Breakdown of academic impact, for papers by Tadeja Pintar Breakdown of academic impact, for papers by Sanja Sädevirta Breakdown of academic impact, for papers by Sanja Stojsavljević Breakdown of academic impact, for papers by Tommy Pacana Breakdown of academic impact, for papers by Vicência Mara Rodrigues de Lima Breakdown of academic impact, for papers by Pedro Fernández-Gil Breakdown of academic impact, for papers by Qian Zhuang Breakdown of academic impact, for papers by Camilla Skoglund-Andersson Breakdown of academic impact, for papers by Han De-wu
Rankless by CCL
2026